D702EC00001: A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig innAdult Participants with Advanced Solid Tumors Previously Treated with Standard of CarenTherapy

rilvegostomig (AZD2936) - AstraZeneca

Feb 18, 2026